Exclusives

MiMedx initiated a 170-patient study to evaluate 2 human amnion/chorion membrane (ppLHACM) products, EPIEFFECT and EPIXPRESS and SoC vs SoC alone in the treatment of non-healing DFUs. Primary outcome measures complete healing in 12 wks....

A 20-patient pilot clinical trial will evaluate the use of borate-based bioactive glass fiber matrix (Mirragen) for treatment of DFUs with primary outcome of complete wound closure at 12 weeks. Not yet recruiting; estimated study completion...

Guard Medical received FDA 510(k) clearance for its NPseal NPWT device for larger incisions, using its previous devices as a predicate. The NPseal 20 and the NPseal 25 are designed for surgically closed incisions up to 20 cm and 25 cm.

Biogennix introduces its new Agilon Surgical Matrix for wounds derived from bovine Type 1 collagen. Upon contact with a new or open wound, it transforms into a gel that maintains a moist, low pH environment and helps form tissue and...

A comparison study found StrataGraft significantly reduced inpatient length of stay (4.84 days) vs autografts in adults with deep partial-thickness burns. Results translate into reduced burden on the healthcare system and lower costs for...

CMS has published the Oct-Dec 2024 quarterly drug pricing files with payment limits for some Part B-covered drugs. A total of 104 skin substitute products had a published ASP, adding 11 new codes. Of these, 9 products had ASPs over $2K and 2...

Spectral AI announced it has received a new award of over $850,000 from the Medical Tech Enterprise Consortium (MTEC) to support the ongoing development of DeepView Snapshot for battlefield assessment. Total non-dilutive government funding...

Merakris announced the FDA has granted clearance to commence Part 2 of its Phase II clinical trial for an investigational new drug study of Dermacyte Liquid. The study will begin in late 2024 in up to 10 clinical sites.

CytaCoat AB entered into a development and licensing agreement with Absorbest AB to bring CytaCoat’s performance-enhancing coating technologies to market in superabsorbent advanced wound dressings. This is CytaCoat’s first commercial deal. No...

A systematic review and meta-analysis of 17 studies compared the effect of silver and iodine dressings on healing time, healing rate, exudate amount, pain, and anti-infective efficacy. It found that silver dressings significantly reduce...